Royalty Pharma plc balance sheet
At the end of its fiscal year on Dec 31, 2025, Royalty Pharma plc reported total assets of $19.62B and shareholders' equity of $9.71B. That works out to liabilities equal to 50% of assets, a current ratio of 2.40 (current assets ÷ current liabilities), long-term debt of 0.88× shareholders' equity.
Balance sheet at each fiscal year end
| Fiscal year ended | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|
| Total assets | — | $12.45B | $16.02B | $17.52B | $16.81B | $16.38B | $18.22B | $19.62B |
| Current assets | — | $832.07M | $2.70B | $2.88B | $2.55B | $1.27B | $1.80B | $1.53B |
| Cash & equivalents | $1.92B | $246.20M | $1.01B | $1.54B | $1.71B | $477.01M | $929.03M | $618.70M |
| Total liabilities | — | $6.31B | $6.12B | $7.27B | $7.29B | $6.30B | $7.88B | $9.91B |
| Current liabilities | — | $333.42M | $307.89M | $171.25M | $1.17B | $161.38M | $1.25B | $636.21M |
| Long-term debt | — | $5.96B | $5.82B | $7.10B | $6.12B | $6.14B | $6.61B | $8.57B |
| Shareholders' equity | $4.55B | $6.14B | $9.90B | $10.25B | $9.53B | $10.08B | $10.34B | $9.71B |
| Reported in | 10-K 2021 | 10-K 2021 | 10-K 2022 | 10-K 2023 | 10-K 2024 | 10-K 2025 | 10-K 2026 | 10-K 2026 |
Balance-sheet figures are point-in-time values on the last day of each fiscal year. Some companies (for example banks and insurers) do not present current assets and liabilities; those cells show —.
Source: SEC EDGAR XBRL company facts for CIK 1802768 (raw data). Most recent filing in this dataset: 10-Q filed Aug 5, 2026. SEC data file dated Nov 3, 2026; page built Nov 5, 2026. Figures are as most recently reported, including restatements. How we select figures.